Fresenius posts profit beat in first quarter, confirms outlook
By Tristan Veyet (Reuters) -German healthcare group Fresenius beat analysts’ operating profit expectations on Wednesday, driven by a strong performance at its drug making division Kabi in the first quarter of 2025. The company’s earnings before interest and taxes (EBIT) excluding special items rose to 654 million euros ($742 million) in the quarter, compared to …
Fresenius posts profit beat in first quarter, confirms outlook Read More »









